Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4542083016 | Margetuximab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4542084010 | Margetuximab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Margetuximab (substance) | est un(e) (attribut) | Human epidermal growth factor receptor 2 inhibitor | true | Inferred relationship | Some | ||
Margetuximab (substance) | est un(e) (attribut) | Monoclonal antibody (substance) | true | Inferred relationship | Some | ||
Margetuximab (substance) | est un(e) (attribut) | protéine inhibitrice d’une enzyme | true | Inferred relationship | Some | ||
Margetuximab (substance) | Has disposition (attribute) | Human epidermal growth factor receptor 2 inhibitor | true | Inferred relationship | Some | ||
Margetuximab (substance) | est un(e) (attribut) | Antineoplastic agent (substance) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Margetuximab-containing product | a pour principe actif (attribut) | True | Margetuximab (substance) | Inferred relationship | Some | 1 |
Margetuximab-containing product in parenteral dose form | a pour principe actif (attribut) | True | Margetuximab (substance) | Inferred relationship | Some | 1 |
Product containing only margetuximab in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | True | Margetuximab (substance) | Inferred relationship | Some | 1 |
Margetuximab only product | a pour principe actif (attribut) | True | Margetuximab (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets